TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-29
DOI
10.3389/fonc.2022.862015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer
- (2021) Ali Ghoochani et al. CANCER RESEARCH
- Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
- (2021) Katherine S. Virgo et al. JOURNAL OF CLINICAL ONCOLOGY
- LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
- (2021) Gege Shu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Broadening horizons: the role of ferroptosis in cancer
- (2021) Xin Chen et al. Nature Reviews Clinical Oncology
- miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549
- (2021) Shi-hua Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling
- (2021) Yangyi Zhang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
- (2021) Zhiyu Song et al. LIFE SCIENCES
- EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2/c-Myc/LDHA signaling
- (2021) Xingkang Jiang et al. CANCER RESEARCH
- Transcription factors in ferroptotic cell death
- (2020) Chongshan Dai et al. CANCER GENE THERAPY
- The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
- (2020) Guang Lei et al. CELL RESEARCH
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539
- (2020) Rui Wang et al. CELL CYCLE
- Long non-coding RNAs regulate drug resistance in cancer
- (2020) Kaisheng Liu et al. Molecular Cancer
- LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
- (2020) Cefan Zhou et al. Molecular Cancer
- Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
- (2020) Xuefei Zhang et al. Cell Death & Disease
- Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
- (2020) Jessica Bordini et al. CLINICAL CANCER RESEARCH
- Gene regulation by long non-coding RNAs and its biological functions
- (2020) Luisa Statello et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TFAP2C-activated MALAT1 modulates the chemoresistance of docetaxel-resistant lung adenocarcinoma cells
- (2019) Jing Chen et al. Molecular Therapy-Nucleic Acids
- LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
- (2019) Zhiqun Shang et al. NUCLEIC ACIDS RESEARCH
- Ferroptosis, a new form of cell death: opportunities and challenges in cancer
- (2019) Yanhua Mou et al. Journal of Hematology & Oncology
- Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
- (2019) Min Wang et al. CELL DEATH AND DIFFERENTIATION
- The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers
- (2019) Damian Kołat et al. BIOSCIENCE REPORTS
- Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke
- (2019) Ishraq Alim et al. CELL
- Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses
- (2019) Boutaina Daher et al. CANCER RESEARCH
- Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma
- (2019) Lijie Huang et al. Cell Death & Disease
- LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
- (2019) Xingkang Jiang et al. CELLULAR SIGNALLING
- Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo
- (2019) Yuki Shibata et al. PLoS One
- Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
- (2019) Hai-Hong Zhou et al. Frontiers in Oncology
- A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53
- (2018) Chao Mao et al. CANCER RESEARCH
- Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
- (2018) Brandon Bumbaca et al. Acta Pharmaceutica Sinica B
- Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
- (2017) Matthew J. Hangauer et al. NATURE
- Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
- (2017) Jong-Lyel Roh et al. Redox Biology
- Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
- (2016) Jong-Lyel Roh et al. CANCER LETTERS
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started